Genomics Innovator Mapmygenome Secures $1.5 Million in Seed Funding for Personalized Health Solutions

Mapmygenome, a company at the forefront of using genomics to personalize health and well-being, announced a recent funding round of $1.5 million. The company, established in 2013, offers at-home DNA tests and diagnostic genomic tests that provide valuable DNA-based insights for consumers, physicians, and health service providers, facilitating a personalized health journey. With a vision to "Touch 100 million lives and save a million lives by 2030," Mapmygenome offers a range of preventive genomic tests such as Genomepatri, BeautyMap, MyFitGene, Cardiomap, MedicaMap, and MapmyBiome. Additionally, MapMyGenome helps individuals explore their ethnic heritage through Genomepatri Heritage. The funding will further support Mapmygenome in its mission to revolutionize personalized healthcare and make a significant impact in the genomics industry.